United States Influenza Treatment Market Size, Share & Trends Analysis Report By Product (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy) and Forecasts, 2024-2032

Last Updated: December 23, 2024 | Author: Debashree B | Format: | Report Code: SR6476DR | Pages: 80

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. United States Influenza Treatment Market Size Analysis
    1. Introduction
    2. United States Influenza Treatment Market Market Size & Forecast By Product 2020-2032 (USD MILLION/ Units)
      1. Peramivir
      2. Zanamivir
      3. Oseltamivir Phosphate
      4. Baloxavir Marboxil
    3. United States Influenza Treatment Market Market Size & Forecast By Distribution Channel 2020-2032 (USD MILLION/ Units)
      1. Retail Pharmacy
      2. Hospital Pharmacy
  7. United States United States Influenza Treatment Market Size Analysis
    1. Introduction
    2. United States Influenza Treatment Market Market Size & Forecast By Product 2020-2032 (USD MILLION/ Units)
      1. Peramivir
      2. Zanamivir
      3. Oseltamivir Phosphate
      4. Baloxavir Marboxil
    3. United States Influenza Treatment Market Market Size & Forecast By Distribution Channel 2020-2032 (USD MILLION/ Units)
      1. Retail Pharmacy
      2. Hospital Pharmacy
  8. Competitive Landscape
    1. United States Influenza Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  9. Market Players Assessment
    1. Roche Holding AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. GlaxoSmithKline plc
    3. AstraZeneca plc
    4. Sanofi S.A.
    5. Seqirus (a subsidiary of CSL Limited)
    6. Johnson & Johnson
    7. Pfizer Inc.
    8. Novartis International AG
    9. Daiichi Sankyo Company, Limited
    10. Mylan N.V.
  10. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  11. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  12. Disclaimer
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: